The report on the Global Gastroesophageal Reflux Disease Therapeutics Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Drivers
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Gastroesophageal Reflux Disease Therapeutics Market
2.2. Global Gastroesophageal Reflux Disease Therapeutics Market Snapshot
3 . GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Gastroesophageal Reflux Disease Therapeutics Market
3.3. Market Restraints of Gastroesophageal Reflux Disease Therapeutics Market
3.4. Opportunities of Gastroesophageal Reflux Disease Therapeutics Market
3.5. Trends of Gastroesophageal Reflux Disease Therapeutics Market
3.6. Porter’s Five Force Analysis of Gastroesophageal Reflux Disease Therapeutics Market
3.7. Gastroesophageal Reflux Disease Therapeutics Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Product Type
3.7.2 Market Attractive Analysis by Distribution Channel
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Gastroesophageal Reflux Disease Therapeutics Value Chain Analysis
4.2. Gastroesophageal Reflux Disease Therapeutics Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Gastroesophageal Reflux Disease Therapeutics Raw Material Manufactures List
4.2.3. Price Trend of Gastroesophageal Reflux Disease Therapeutics Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MARKET ANALYSIS BY PRODUCT TYPE
5.1 Overview by Product Type
5.2 Global Gastroesophageal Reflux Disease Therapeutics Market Analysis by Product Type
5.3 Market Analysis of Antacids by Regions
5.4 Market Analysis of Proton pump inhibitors by Regions
5.5 Market Analysis of H2 receptor blocker by Regions
5.6 Market Analysis of Pro kinetic agents by Regions
5.7 Market Analysis of Dopamine receptor antagonist by Regions
5.8 Market Analysis of EndoCinch by Regions
5.9 Market Analysis of Stretta by Regions
5.10. Market Analysis of EsophyX by Regions
5.11 Market Analysis of Transoral Incisionless fundoplication by Regions
5.12 Market Analysis of Linx by Regions
6 . GLOBAL GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6.1 Overview by Distribution Channel
6.2 Global Gastroesophageal Reflux Disease Therapeutics Market Analysis by Distribution Channel
6.3 Market Analysis of Hospital pharmacy by Regions
6.4 Market Analysis of Drug stores by Regions
6.5 Market Analysis of General stores by Regions
6.6 Market Analysis of Supermarkets by Regions
7 . GLOBAL GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America
7.3.1. Overview
7.3.2. North America Gastroesophageal Reflux Disease Therapeutics Market Estimate by Market Segment
7.3.3. North America Gastroesophageal Reflux Disease Therapeutics Market Estimate by Country
7.3.4. United State
7.3.5. Rest of North America
7.4. Europe
7.4.1. Overview
7.4.2. Europe Gastroesophageal Reflux Disease Therapeutics Market Estimate by Market Segment
7.4.3. Europe Gastroesophageal Reflux Disease Therapeutics Market Estimate by Country
7.4.4. United Kingdom
7.4.5. France
7.4.6. Germany
7.4.7 Rest of Europe
7.5. Asia Pacific
7.5.1. Overview
7.5.2. Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market Estimate by Market Segment
7.5.3. Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market Estimate by Country
7.5.4. China
7.5.5. Japan
7.5.6. India
7.5.7. Rest of Asia Pacific
7.6. Latin America
7.6.1. Overview
7.6.2. Latin America Gastroesophageal Reflux Disease Therapeutics Market Estimate by Market Segment
7.6.3. Latin America Gastroesophageal Reflux Disease Therapeutics Market Estimate by Country
7.6.4. Brazil
7.6.5. Rest of Latin America
7.7. Middle East & Africa
7.7.1. Overview
7.7.2. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Estimate by Market Segment
7.7.3. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Estimate by Country
7.7.4. Middle East
7.7.5. Africa
8 . COMPETITIVE LANDSCAPE OF THE GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS COMPANIES
8.1. Gastroesophageal Reflux Disease Therapeutics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments
9 . COMPANY PROFILES OF GASTROESOPHAGEAL REFLUX DISEASE THERAPEUTICS INDUSTRY
9.1. Company Share Analysis
9.2. Market Concentration Rate
9.3. AstraZeneca
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products
9.3.4. Recent Developments
9.4. Addex Pharmaceuticals
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products
9.4.4. Recent Developments
9.5. Vecam
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products
9.5.4. Recent Developments
9.6. Medigus
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products
9.6.4. Recent Developments
9.7. Peer Medical
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products
9.7.4. Recent Developments
9.8. EndoGastric Solutions
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products
9.8.4. Recent Developments
9.9. Eisai Co., Ltd
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products
9.9.4. Recent Developments
9.10. Takeda Pharmaceutical Company Limited
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products
9.10.4. Recent Developments
9.11. RaQualia Pharma Inc.
9.11.1. Company Overview
9.11.2. Financials
9.11.3. Products
9.11.4. Recent Developments
9.12. Reviva Pharmaceuticals Inc.
9.12.1. Company Overview
9.12.2. Financials
9.12.3. Products
9.12.4. Recent Developments
9.13. Rottapharm Madaus
9.13.1. Company Overview
9.13.2. Financials
9.13.3. Products
9.13.4. Recent Developments
9.14. Torax Medical
9.14.1. Company Overview
9.14.2. Financials
9.14.3. Products
9.14.4. Recent Developments
9.15. Mederi Therapeutics
9.15.1. Company Overview
9.15.2. Financials
9.15.3. Products
9.15.4. Recent Developments
9.16. Aros Pharma
9.16.1. Company Overview
9.16.2. Financials
9.16.3. Products
9.16.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..